| Q92001760 | A Rare Case of Early Onset Multiple Myeloma in a 20-Year-Old Female With Factor X Inhibitor |
| Q92798258 | A Rare Presentation of Multiple Myeloma: A Case Report of Hepatic Amyloidosis |
| Q41877770 | A Very Rare Presentation of Multiple Myeloma: Unilateral Raccoon Eye. |
| Q34788114 | A case of multiple myeloma in a poultry worker |
| Q42375505 | An audit of immunofixation requesting practices at a South African referral laboratory |
| Q88797007 | Bloodless tandem autologous transplant in Jehovah's Witness patients |
| Q64072895 | Chidamide, a novel histone deacetylase inhibitor, inhibits multiple myeloma cells proliferation through succinate dehydrogenase subunit A |
| Q36331737 | Combination of cyclophosphamide, etoposide, carboplatin and dexamethasone as a salvage regimen for refractory multiple myeloma patients: a comparison with a historical control group. |
| Q55311492 | Comparative analysis of the surgical treatment results for multiple myeloma bone disease of the spine and the long bone/soft tissue. |
| Q37721007 | Definitive diagnosis of multiple myeloma from rib specimens resected at thoracotomy in a patient with lung cancer |
| Q37208511 | Delays in referral and diagnosis for chronic hematologic malignancies: a literature review |
| Q33698897 | Diagnostic delay and complications for older adults with multiple myeloma |
| Q89824526 | Differential Pain-Related Behaviors and Bone Disease in Immunocompetent Mouse Models of Myeloma |
| Q26821981 | Does my patient with a serum monoclonal spike have multiple myeloma? |
| Q58780887 | Early detection of multiple myeloma in primary care using blood tests: a case-control study in primary care |
| Q37868637 | Guidelines for supportive care in multiple myeloma 2011. |
| Q47248893 | Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy |
| Q42286732 | Hypoglossal Nerve Mononeuropathy as the First Presenting Symptom of Progressing Multiple Myeloma |
| Q27000171 | Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review |
| Q64234835 | Levels of CEACAM6 in Peripheral Blood Are Elevated in Patients with Plasma Cell Disorders: A Potential New Diagnostic Marker and a New Therapeutic Target? |
| Q38555091 | Limiting early mortality: Do's and don'ts in the management of patients with newly diagnosed multiple myeloma |
| Q39001325 | Management of Elderly Patients with Plasma Cell Myeloma |
| Q64101284 | Methods for reducing delays in the diagnosis of multiple myeloma |
| Q58718878 | Morphometrics predicts overall survival in patients with multiple myeloma spine metastasis: A retrospective cohort study |
| Q42136513 | Multiple myeloma and atopic eczema in an adult |
| Q41078986 | Multiple myeloma can be accurately diagnosed in acute kidney injury patients using a rapid serum free light chain test |
| Q33578273 | Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study |
| Q40279004 | Multiple myeloma: the quality of care is linked to geographical and organisational determinants. A study in a French registry |
| Q38246241 | Myeloma bone disease: pathogenesis, current treatments and future targets |
| Q52607534 | Myeloma: Patient accounts of their pathways to diagnosis. |
| Q36728590 | Pathological burst fracture in the cervical spine with negative red flags: a case report |
| Q34243733 | Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death |
| Q55364471 | Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis. |
| Q35076000 | Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic records |
| Q36295008 | Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma |
| Q90245548 | Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunction |
| Q38692861 | Statin use and risk of multiple myeloma: An analysis from the cancer research network. |
| Q40190273 | Streptococcus pneumoniae bacteraemia leading to the diagnosis of multiple myeloma |
| Q37150733 | The Diagnosis and Treatment of Multiple Myeloma |
| Q92519528 | Time from Symptom Onset to Diagnosis and Treatment among Haematological Malignancies: Influencing Factors and Associated Negative Outcomes |
| Q34252897 | Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network |
| Q57053928 | What is the significance of monoclonal gammopathy of undetermined significance? |